NetraMark Holdings (XCNQ:AIAI) Current Accrued Expense : C$0.24 Mil (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is NetraMark Holdings Current Accrued Expense?

NetraMark Holdings's Current Accrued Expense for the quarter that ended in Mar. 2024 was C$0.24 Mil.

NetraMark Holdings's quarterly Current Accrued Expense declined from Sep. 2023 (C$0.80 Mil) to Dec. 2023 (C$0.28 Mil) and declined from Dec. 2023 (C$0.28 Mil) to Mar. 2024 (C$0.24 Mil).

NetraMark Holdings's annual Current Accrued Expense increased from Sep. 2021 (C$0.46 Mil) to Sep. 2022 (C$1.06 Mil) but then declined from Sep. 2022 (C$1.06 Mil) to Sep. 2023 (C$0.80 Mil).

NetraMark Holdings Current Accrued Expense Historical Data

The historical data trend for NetraMark Holdings's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NetraMark Holdings Current Accrued Expense Chart

NetraMark Holdings Annual Data

Trend

Sep20

Sep21

Sep22

Sep23

Current Accrued Expense

0.14

0.46

1.06

0.80

NetraMark Holdings Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Sep23	Dec23	Mar24
Current Accrued Expense	Get a 7-Day Free Trial										0.94	1.16	0.80	0.28	0.24

NetraMark Holdings Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.

NetraMark Holdings Current Accrued Expense Related Terms

Thank you for viewing the detailed overview of NetraMark Holdings's Current Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

NetraMark Holdings (XCNQ:AIAI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » NetraMark Holdings Inc (XCNQ:AIAI) » Definitions » Current Accrued Expense

Comparable Companies

Traded in Other Exchanges

AINMF:USA

Address

1655 Dupont Street, Suite 101, Toronto, ON, CAN, M6P 3T1

Website

https://www.nurosene.com

NetraMark Holdings Inc is focused on the application of a totally unique Artificial Intelligence (AI) / Machine Learning (ML) solution targeted at the pharmaceutical industry in order to de-risk clinical trials. NetraMark has a proprietary technology that is capable of cutting through the combinatorial complexity that comes with dealing with heterogeneous patient populations to extract precisely defined personas of patients with respect to placebo and drug response, in addition to tolerability and adverse events. By using the client's own contemporaneous data, and having the capacity to learn from small data, the NetraAI tech extracts these personas to equip pharmaceutical companies with strategies to optimize their next trials for success.

Executives

Andrew Parks

Director

NetraMark Holdings (XCNQ:AIAI) Headlines

No Headlines